Qi Tan

机构：Harvard University, Harvard Global Health Institute · ORCID：0000-0001-8282-1061

发表论文 38 篇 · 总被引 203 次 · h-index 8

代表论文

• Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways (2022 · International Journal of Medical Sciences · 被引 39)
• Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition (2020 · Drug Design Development and Therapy · 被引 27)
• The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis (2015 · Archives of Medical Science · 被引 24)
• Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients (2019 · Infection and Drug Resistance · 被引 23)
• Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis (2017 · Scientific Reports · 被引 21)
• Identification of robust genetic signatures associated with lipopolysaccharide-induced acute lung injury onset and astaxanthin therapeutic effects by integrative analysis of RNA sequencing data and GEO datasets (2020 · Aging · 被引 14)